P-Nitrophenol

P-Nitrophenol

SCHEMBL407205

O=P(O)(O)O.O=[N+]([O-])c1ccc(O)cc1.[NaH].[NaH]

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of P-Nitrophenol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.55
CA2 P00918 3/20 0.55
CES1 P23141 2/20 0.55
CES2 O00748 1/20 0.55
AKR1C3 P42330 1/20 0.55
CA12 O43570 2/20 0.50
MMP2 P08253 2/20 0.50
MMP9 P14780 1/20 0.50
MMP8 P22894 1/20 0.50
MMP14 P50281 1/20 0.50
PTGS2 P35354 2/20 0.47
PTGS1 P23219 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
ALDH1A1 P00352 2/20 0.46
ACHE P22303 1/20 0.46
HSD17B10 Q99714 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
P-Nitrophenol SCHEMBL6681729 1.00 CA1 (0.55) CA1CA2CES1CES2AKR1C3
P-Nitrophenol SCHEMBL28493361 0.98 CA1 (0.57) CA1CA2CES1CES2AKR1C3
P-Nitrophenol SCHEMBL161007 0.98 CA1 (0.57) CA1CA2CES1CES2AKR1C3
P-Nitrophenol SCHEMBL27623918 0.96 CA1 (0.55) CA1CA2CES1CES2AKR1C3
P-Nitrophenol SCHEMBL2057324 0.91 CES1 (0.56) CA1CA2CES1PTGS2PTGS1
P-Nitrophenol SCHEMBL27587772 0.91 CES1 (0.56) CA1CA2CES1PTGS2PTGS1
P-Nitrophenol SCHEMBL407206 0.89 CA1 (0.53) CA1CA2CES1CES2AKR1C3
P-Nitrophenol SCHEMBL17512809 0.89 CA1 (0.53) CA1CA2CES1CES2AKR1C3
P-Nitrophenol SCHEMBL9684585 0.89 CA1 (0.53) CA1CA2CES1CES2AKR1C3
P-Nitrophenol SCHEMBL16554130 0.89 CA1 (0.53) CA1CA2CES1CES2AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117399072-A Ultra-small cerium-based metal organic framework nano enzyme and preparation method and application thereof 华南理工大学 2024-01-16 CN claimed
CN-122070150-A Composition containing BMP-2, and preparation method and application thereof 杭州九源基因生物医药股份有限公司 2026-05-19 CN disclosed
EP-3473706-B1 CELL-EMBEDDED BEADS FOR HAIR REGENERATION AND METHOD FOR PRODUCING SAME, AND KIT FOR HAIR REGENERATION NAT UNIV CORP YOKOHAMA NAT UNIV (JP) 2025-09-10 EP disclosed
CN-119950495-A Use of compound for interfering integrin beta 3/Src interaction 上海交通大学医学院附属瑞金医院 2025-05-09 CN disclosed
CN-113967210-B Use of compound for interfering integrin beta 3/Src interaction 上海交通大学医学院附属瑞金医院 2025-02-07 CN disclosed
US-12018086-B2 Kit comprising contiguous nucleobases, including position 76, of RS5745994 CEDARS-SINAI MEDICAL CENTER (US) 2024-06-25 US disclosed
CN-117399072-A Ultra-small cerium-based metal organic framework nano enzyme and preparation method and application thereof 华南理工大学 2024-01-16 CN disclosed
US-20220153855-A1 METHODS OF PREDICTING NON-RESPONSE TO ANTI-TNF TREATMENT IN SUBJECTS WITH INFLAMMATORY BOWEL DISEASE CEDARS-SINAI MEDICAL CENTER 2022-05-19 US disclosed
US-11236393-B2 Methods of determining responsiveness to anti-TNFα therapy in inflammatory bowel disease CEDARS-SINAI MEDICAL CENTER (US) 2022-02-01 US disclosed
US-11180565-B2 Method of enriching a target nucleic acid at a TNFRSF1B gene locus in a sample from a subject with inflammatory bowel disease CEDARS-SINAI MEDICAL CENTER (US) 2021-11-23 US disclosed
US-5691151-A DETECTION OF ANTIBODY REGENTS OF UNIVERSITY OF CALIFORNIA (US) 1997-11-25 US disclosed
US-5681699-A ASSAYING NUCLEIC ACID SAMPLE FOR THE PRESENCE OF A CODON ENCODING ARGININE AT AMINO ACID POSITION 241 OF INTERCELLULAR ADHESION MOLECULE-1 CEDARS-SINAI MEDICAL CENTER (US) 1997-10-28 US disclosed
WO-1996041183-A1 DIFFERENTIAL ASSAY FOR ULCERATIVE COLITIS, PRIMARY SCLEROSING CHOLANGITIS AND TYPE 1 AUTOIMMUNE HEPATITIS CEDARS-SINAI MEDICAL CENTER (US) 1996-12-19 WO disclosed
WO-1996012189-A2 METHODS OF SCREENING FOR ULCERATIVE COLITIS AND CROHN'S DISEASE BY DETECTING VH3-15 AUTOANTIBODY AND pANCA CEDARS-SINAI MEDICAL CENTER (US) 1996-04-25 WO disclosed
EP-0615129-A2 Methods for selectively detecting perinuclear anti-neutrophilcytoplasmic antibody of ulcerative colitis or primary sclerosing cholangitis Cedars-Sinai Medical Center (US) 1994-09-14 EP disclosed
WO-1992002819-A2 ASSAY FOR ULCERATIVE COLITIS AND PRIMARY SCLEROSING CHOLANGITIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1992-02-20 WO disclosed
EP-0182179-B1 INTEGRAL MULTILAYER ANALYTICAL ELEMENT FOR USE IN THE MEASUREMENT OF ALKALINE PHOSPHATASE ACITIVITY FUJI PHOTO FILM CO., LTD. (JP) 1989-10-18 EP disclosed
US-4797476-A Mono-4-arylazoaryl phosphoric esters FUJI SHASHIN FILM KABUSHIKI KAISHA (JP) 1989-01-10 US disclosed
EP-0182179-A1 Integral multilayer analytical element for use in the measurement of alkaline phosphatase acitivity FUJI PHOTO FILM CO., LTD. (JP) 1986-05-28 EP disclosed
EP-0061731-A2 Novel phosphoric ester and a method for quantitative analysis of an alkaline phosphatase using the same as a substrate Fuji Photo Film Co., Ltd. (JP) 1982-10-06 EP disclosed